Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evogene (EVGN) Long-Term Investments (2024 - 2025)

Historic Long-Term Investments for Evogene (EVGN) over the last 5 years, with Q2 2025 value amounting to $15000.0.

  • Evogene's Long-Term Investments fell 8500.0% to $15000.0 in Q2 2025 from the same period last year, while for Jun 2025 it was $15000.0, marking a year-over-year decrease of 8500.0%. This contributed to the annual value of $82000.0 for FY2024, which is N/A changed from last year.
  • Latest data reveals that Evogene reported Long-Term Investments of $15000.0 as of Q2 2025, which was down 8500.0% from $80000.0 recorded in Q1 2025.
  • In the past 5 years, Evogene's Long-Term Investments ranged from a high of $133000.0 in Q1 2024 and a low of $15000.0 during Q2 2025